Cancer can ravish both the body and mind. It can also affect the lives of everyone within the affected person’s circle. Fortunately, huge strides are being made in the fight against cancer. Eric Leftkofsky is brilliant man who also happens to be a billionaire entrepreneur assisting in the fight against cancer.
However, his fight against cancer has nothing to do with money. For him, it is all about helping fight disease that claims the lives of millions of people. His success does allow him to navigate a world that many may not understand. His experience, connections, and education allow him to get things done.
Eric Leftkofsky helped co-found Tempus. This is a moment in society where precision medicine is possible. Tempus is helping to create the technology that will build the world’s greatest library of personal medical data. The data will be both clinical and molecular, and it will be immediately accessible so doctors can help their cancer patients in real-time.
The Tempus mission is to redefine how doctors can use genomic data in clinical settings. Patients will benefit when doctors have access to an infinite amount of data concerning them and their fight with cancer. Patients can also clearly benefit by those who have come before them. Physicians have the tools to learn as the system gathers more data.
Tempus will allow a cancer patient’s data to store in a single location. This enables doctors to make real-time decisions that will rely heavily on that data. There are millions of patients diagnosed and treated for cancer. Tempus will enable doctors to have access to how patients have responded to treatments, and to offer more effective solutions for their own patients.
He is also a philanthropist, and founded the Lefkoftsky Family Foundation with his wife to advance initiatives that will help enhance the lives of people in their own communities. His other affiliations include World Business Chicago, and the Museum of Science and Industry to name several.
Dr. David Samadi is a world renowned, board-certified urologist and is currently the Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York City. He specializes in the treatment of urologic disease, prostate cancer, and kidney cancer. Dr. Samadi is a member of the American Urologic Association and the American Medical Association.
Dr. Samadi grew up in Iran, but left the country at the age of 15 with his younger brother. He completed high school in New York, then went on to Stony Brook on a full scholarship where he earned a biochemistry degree. Dr. Samadi later earned his M.D. from S.U.N.Y, Stony Brook School of Medicine in Stony Brook New York. Finally, Dr. Samadi finished his postgraduate training in urology and proctology at Montefiore Medical Center and in proctology at Albert Einstein College of Medicine.
Dr. Samadi is an expert in robotic prostate surgery and he invented a treatment for the removal of prostate cancer called the Samadi Modified Advanced Robotic Treatment (SMART). Remarkably, almost 90% of Dr. Samadi’s patients have become cancer-free since undergoing this treatment with Dr. Samadi.
He currently has completed over 7,000 successful robotic prostate surgeries, is ranked one of the top 3 best urologists in New York, was named to Castle Connoly America’s Top Doctors and New York Magazine’s Best Doctor’s List. It’s little surprise that patients travel from all over the world to be seen by him.
Dr. Samadi is also well-known for his presence on television. He has been featured in Forbes and on Good Morning America and Fox News. He also hosts “Dr. Samadi TV”, where he discusses various topics within the medical field, not just urology and prostate cancer. Dr. Samadi gained notoriety recently as he wrote an article for the Huffington Post regarding prostate cancer surgery and commented on Mitt Romney’s recent prostate surgery, revealing that Mr. Romney’s prognosis was “good”.
Besides being an expert in his field, Dr. Samadi is also known has being a deeply caring person–both in and out of the hospital. He puts other’s comfort at the top of his priorities. He even designed a special floor for his patients which was ranked highest in a patient satisfaction survey, an honor he is very proud of.
Dr. David Samadi was born and raised in the Persian Jewish community of Iran. At age fifth-teen, three years after the Iranian revolution began, he was forced to leave Iran and move to a community in Belgium. Even though his life was turned upside down he endeavored to continue his education both in Belgium and in London. In 1984 he moved to Roslyn, New York; where he had was able to finish high school in.
A gifted student, he received a full scholarship to attended Stony Broke University and earned his degree in biochemistry. In 1994 he earned a master degree from S.U.N.Y., Stony Brook School of Medicine. He finished his postgraduate training in proctology at Albert Einstein College of Medicine, then subsequently attended Montefiore Medical Center where he completed his Urology training in 2000. Next Dr. David Samadi completed an oncology fellowship in proctology at Memorial Sloan-Kettering Cancer Center. He later accomplished a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France in 2002. Even as an accomplished notable Doctor, Dr. David Samadi is always learning and striving to improve himself or the tools he used.
Dr. David Samadi’s invented a revolutionary robotic surgery technic named SMART (Samadi Modified Advanced Robotic Technique). It was designed to replace prostatectomy open surgery with a minimally invasive alternative using the da Vinci Surgical System, which reduces operative times and postoperative complication rates. This revolutionary technique was a culmination of his attentive focus, countless hours of surgeries, and an innovative mindset.
Dr. David Samadi had humble beginnings and constantly endeavored to improve himself; in turn, he improved the world. His notable accomplishments and abilities enabled him to become the current chairman of Urology, Program Director of Urology Residency and Chief of Robotic Surgery at Lenox Hill Hospital. Never-ceasing to find ways to improve the world he also has a show and a website, known as Dr. David Samadi TV, which teaches on a wide variety of subjects: Diet, sex, cancer, etcetera. His unparalleled expertise in his field, match with his determination to improve the world has gained him an audience from around the world. As a young man he was forced to flee Iran, now thousands of people are running to him.
Cancer is one of the largest killers in America. In fact, all-cause cancer mortality is among the top three causes of death in the country. Now, one network of clinics is using innovative techniques to increase the chances of survival for cancer patients across the country. This network, Cancer Treatment Centers of America (CTCA), is at the forefront on the war against cancer.
What sets CTCA apart from other clinics is the individual treatment for each person who walks through the door. You see, while there is a finite number of types of cancer. No two patients are the same. An elderly lung cancer patient will have different needs and require a different type of treatment than a young lung cancer patient. Recognizing those individual needs, CTCA has created an innovative customized program to treat each person with a unique regimen.
By treating only cancer, the experts and specialists at CTCA know every angle of every part of the treatment process. From diagnosis to medical treatment, counseling, and aftercare, CTCA creates a clear and comprehensive roadmap for each patient. The result is a treatment program that helps the patient stay stronger and potentially increases their odds of recovery with fewer chances of harmful side effects.
Some of the innovative treatments at CTCA include treating cancer on a cellular level with immunotherapy, targeted therapy as well as advanced genomic testing. This targeted therapy helps to better target cancer and treat it with less intrusion to the surrounding organs. Also available is a newly implemented Targeted Agent and Profiling Utilization Registry (TAPUR) study. This study, now in its clinical stage, helps match drugs to specific mutations in a tumor. Available at all five of CTCA clinics. This new study is next level treatment for patients with any and all types of cancer.
With offices in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa, CTCA has a presence across the country. The hundreds of dedicated and qualified cancer specialist work tirelessly to find the right solution for each patient. As a dedicated cancer treatment center, each patient gains an edge against cancer. And that edge can make all the difference.
Cancer Treatment Centers of America has a long and successful experience in the treatment of cancer because that is all that they do. They do not venture out into any other medical area but just concentrate on cancer treatment. They believe in treating the whole patient, meaning that there are are many other side-effects that this dread disease brings along with it.
For example most people are not aware that nearly 80 percent of the people who suffer from cancer are undernourished. One in three patients who are being treated for cancer still suffers pain after treatment begins. Seven out of ten patients with cancer undergo consistent fatigue. Less than one in five cancer patients receive any kind of spiritual support.
Cancer Treatment Centers of America provides care and treatment all under one roof at one of their hospitals, strategically located in Atlanta, Philadelphia, Chicago, Tulsa, and Phoenix. The treatment received is called Integrative Care. This means that the traditional types of treatment are offered such as chemotherapy, surgery, and radiation therapy, but additional supportive therapies are available too.
These supportive therapies include pain management, mind-body medicine, naturopathic medicine, acupuncture. chiropractic care, spiritual support, nutrition therapy, and oncology rehabilitation.
Each person receives an individual treatment plan because cancer attacks person in different ways. A thorough evaluation is made of the patient and then a specific treatment plan is designed for that patient by the team of doctors assigned to that patient. The team, or collaborative approach has been found to be an excellent approach to defeating the cancer of CTCA patients.
All of the physicians and personnel at Cancer Treatment Centers of America specialize in their various fields and they are top of the line professionals. Using the latest in technology and treatment plans, and tools of precision medicine, the highly trained staff has been successful in the treatment and defeat of cancer in its entirety.